drug
(dienogest + estradiol valerate)
Marketedupdated 3mo agoby Bayer HealthCare Pharmaceuticals Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying (dienogest + estradiol valerate)
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jan 30, 2028
~1.5 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- Jan 30, 2028method-of-use (U-1240)US 81536161.5y
- May 13, 2026formulationUS 8071577
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 32m ago
Found something off?
comments(0)
5-min edit window · permanent after that